Tech Company Financing Transactions
CeNeRx BioPharma Funding Round
Aisling Capital, L Capital Partners and Pappas Ventures participated in a $15 million Series B capital raise for CeNeRx BioPharma. The financing round was announced on 10/17/2008.
Transaction Overview
Company Name
Announced On
10/17/2008
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
CeNeRx plans to use the proceeds to conduct a Phase II clinical trial of its lead product candidate Tyrima(TM) for the treatment of major depressive disorder (MDD), to further characterize its novel preclinical cannabinoid pipeline and potentially to acquire additional development stage compounds targeted at CNS disorders.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
270 Cornerstone Dr. 103
Cary, NC 27519
USA
Cary, NC 27519
USA
Phone
Website
Email Address
Overview
CeNeRx (SEN-er-ex) is a privately held clinical stage company developing and commercializinginnovative and improved treatments for diseases of the central nervous system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barry Brand
Browse more venture capital transactions:
Prev: 10/16/2008: Micronics venture capital transaction
Next: 10/17/2008: V.i. Laboratories venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs